Medtronic neurostimulators are small implants with a battery, lead, and an external programming device to access data and adjust your programming.
Discover a sensing-enabled recharge-free DBS system:
Percept™ PC with BrainSense™ technology* captures brain signal data directly from your implanted lead so your physician can adjust stimulation settings to personalize therapy for the best possible outcome.*
The SenSight™ directional lead precisely directs stimulation so you get therapy right where you need it.
Percept™ PC neurostimulator provides full-body MR conditional† access for both 3T and 1.5T MRI scans.
A smartphone-like patient programmer allows you to easily and conveniently manage your therapy and check the neurostimulator (battery).
Explore the 15-year rechargeable DBS system that's designed to fit around your life.
The rechargeable neurostimulator (battery) lasts up to 15 years‡ between replacements.
The SenSight™ directional lead precisely directs stimulation-so you get therapy right where you need it.
The wireless recharger enables mobility while charging.
MRI access is available should you need one in the future. Activa™ RC neurostimulator provides full-body MR conditional† access for 1.5T MRI scans.
The smartphone-like patient programmer allows you to easily and conveniently manage your therapy and check the battery.
As a global leader in medical technology, we continually seek ways to improve the lives of people. Development of DBS therapy started in 1987 and Medtronic has been a leader in the field ever since. Medtronic DBS therapy for tremor control was approved by the U.S. Food and Drug Administration in 1997.
Approximately 7 out of 10 DBS-eligible patients with movement disorders may need an MRI within 10 years of receiving their device.1
This is why we developed the first full-body MR Conditional† DBS system — which gives you access to this important diagnostic imaging tool should you need it in the future.
With a complete Medtronic system — lead, extension, and neurostimulator — you get:
Signal may not be present or measurable in all patients. Clinical benefits of brain sensing have not been established.
Medtronic DBS systems are MR Conditional and safe in the MR environment as long as certain conditions are met. If these conditions are not met, there is a significant risk of tissue lesions from component heating, especially at the lead electrodes, resulting in serious and permanent injury, including coma, paralysis, or death. Refer to the MRI guidelines for Medtronic deep brain stimulation systems for a complete list of conditions: professional.medtronic.com/mri.
Activa™ RC devices eligible for the service life extension and the supplemental limited warranty are those devices sold in the US that have been successfully interrogated with the Medtcronic Activa™ clinician programmer prior to reaching end of service (EOS). For additional information, contact firstname.lastname@example.org.
Falowski S, Safriel Y, Ryan M, Hargens L. The rate of magnetic resonance imaging in patients with deep brain stimulation. Stereotact Funct Neurosurg. 2016; 94:147−153.